Download PDF
Arthritis und Rheuma 2016; 36(01): 37-39
DOI: 10.1055/s-0037-1616802
Kinder-rheumatologie/Der besondere Fall
Schattauer GmbH

Ungewöhnliche Manifestationen einer IgG4-assoziierten Erkrankung

D. Ernst
1   Medizinische Hochschule Hannover, Klinik für Immunologie und Rheumatologie
,
U. Lang
2   Klinikum Herford, Pathologie
,
R.E. Schmidt
1   Medizinische Hochschule Hannover, Klinik für Immunologie und Rheumatologie
,
T. Witte
1   Medizinische Hochschule Hannover, Klinik für Immunologie und Rheumatologie
› Author Affiliations
Further Information

Publication History

Publication Date:
22 December 2017 (online)

    Permissions and Reprints

 

 

  • Literatur

  • 1 Hamano H, Kawa S, Horiuchi A. High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis. N Engl J Med 2001; 344: 732-738.
    CrossrefPubMedGoogle Scholar
  • 2 Loock J, Manger B. IgG4 related disease. Z Rheumatol 2013; 72: 151-162.
    CrossrefPubMedGoogle Scholar
  • 3 Kamisawa T, Anjiki H, Egawa N, Kubota N. Allergic manifestations in autoimmune pancreatitis. Eur J Gastroenterol Hepatol 2009; 21: 1136-1139.
    CrossrefPubMedGoogle Scholar
  • 4 Yamamoto M, Takahashi H, Shinomura Y. Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist. Nat Rev Rheumatol 2014; 10: 148-159.
    CrossrefPubMedGoogle Scholar
  • 5 Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemix disease. Arthritis Rheum 2010; 62: 1755-1762.
    CrossrefPubMedGoogle Scholar
  • 6 Khosroshahi A, Carruthers MN, Deshpande V. et al. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 2012; 91: 57-66.
    CrossrefPubMedGoogle Scholar
  • 7 Yamamoto M, Takahashi H, Naishiro Y. et al. Efficacy of rituximab and other immunosuppressants for IgG4-related disease. Ann Rheum Dis 2012; 71 (Suppl. 03) 290.
    Google Scholar